Oliver Clauß

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [18F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain

M. Scheunemann, P. Brust, K. Kopka, 2022, Pharmaceuticals.

Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET.

G. Bormans, M. Scheunemann, P. Brust, 2022, Journal of Medicinal Chemistry.

OIn vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain.

Jelena Z. Penjišević, P. Brust, W. Deuther-Conrad, 2021, Bioorganic & medicinal chemistry letters.